E09.32
Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy
Clinical Classification Guidelines
Inclusion Terms
- Drug or chemical induced diabetes mellitus with nonproliferative diabetic retinopathy NOS
7th Character Definition
One of the following 7th characters is to be assigned to codes in subcategory E09.32 to designate laterality of the disease:
Medical Intelligence & Overview
ICD-10 code E09.32 refers to a specific form of diabetes mellitus caused by drugs or chemicals. This condition is characterized by mild nonproliferative diabetic retinopathy, a type of eye damage that can occur due to diabetes. Unlike typical diabetes, drug or chemical-induced diabetes results from exposure to certain substances that interfere with the body's insulin production or usage. The presence of diabetic retinopathy indicates that high blood sugar levels have affected the blood vessels in the eyes, but in its mild form, this damage is less severe and often manageable with proper care.
Causes & Symptoms
Clinical Causes: Use of certain medications such as glucocorticoids or other corticosteroids Exposure to specific chemicals like heavy metals or toxins Other pharmaceuticals that impair insulin function or secretion Prolonged or high-dose medication regimen affecting blood sugar regulation
Key Symptoms: Increased thirst and hunger Frequent urination Unexplained weight loss or gain Fatigue and weakness Blurred or fluctuating vision due to eye vessel changes Presence of mild eye abnormalities related to diabetic retinopathy
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves reviewing a patient's medical history, especially medication or chemical exposure, along with blood tests such as fasting glucose, HbA1c, and oral glucose tolerance. Eye examinations, including retinal imaging, help identify the degree of retinopathy. The clinician may also rule out other causes of diabetic change or eye damage. The specific ICD-10 code confirms the diagnosis of drug or chemical-induced diabetes with mild nonproliferative diabetic retinopathy.
Treatment Protocols: Management focuses on controlling blood sugar levels and addressing the underlying cause, such as discontinuing the offending medication under medical supervision. Blood glucose monitoring, dietary modifications, physical activity, and possibly medications like insulin or oral hypoglycemics are common. Regular eye examinations are essential to monitor retinopathy progression. In mild cases, maintaining blood sugar within target ranges can prevent worsening of eye damage and other complications.
Clinical Advice & FAQs
Billing Guidance
Is E09.32 a billable ICD-10 code?
Yes, E09.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.32?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference